Fusion Pharmaceuticals Price Prediction
| FUSNDelisted Stock | USD 3.75 0.33 8.09% |
Oversold Vs Overbought
43
Oversold | Overbought |
Using Fusion Pharmaceuticals hype-based prediction, you can estimate the value of Fusion Pharmaceuticals from the perspective of Fusion Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Fusion Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Fusion because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Fusion Pharmaceuticals after-hype prediction price | USD 3.75 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Fusion |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Fusion Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Fusion Pharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of Fusion Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Fusion Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Fusion Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Fusion Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Fusion Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Fusion Pharmaceuticals' historical news coverage. Fusion Pharmaceuticals' after-hype downside and upside margins for the prediction period are 3.75 and 3.75, respectively. We have considered Fusion Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Fusion Pharmaceuticals is very steady at this time. Analysis and calculation of next after-hype price of Fusion Pharmaceuticals is based on 3 months time horizon.
Fusion Pharmaceuticals Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Fusion Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Fusion Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Fusion Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 0 Events / Month | 14 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
3.75 | 3.75 | 0.00 |
|
Fusion Pharmaceuticals Hype Timeline
Fusion Pharmaceuticals is currently traded for 3.75. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Fusion is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on Fusion Pharmaceuticals is about 0.0%, with the expected price after the next announcement by competition of 3.75. About 87.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 1.4. Fusion Pharmaceuticals had not issued any dividends in recent years. Given the investment horizon of 90 days the next projected press release will be in a few days. Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.Fusion Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Fusion Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Fusion Pharmaceuticals' future price movements. Getting to know how Fusion Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Fusion Pharmaceuticals may potentially react to the hype associated with one of its peers.
Fusion Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Fusion price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Fusion using various technical indicators. When you analyze Fusion charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Fusion Pharmaceuticals Predictive Indicators
The successful prediction of Fusion Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Fusion Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Fusion Pharmaceuticals based on analysis of Fusion Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Fusion Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Fusion Pharmaceuticals's related companies.
Story Coverage note for Fusion Pharmaceuticals
The number of cover stories for Fusion Pharmaceuticals depends on current market conditions and Fusion Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Fusion Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Fusion Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Fusion Pharmaceuticals Short Properties
Fusion Pharmaceuticals' future price predictability will typically decrease when Fusion Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Fusion Pharmaceuticals often depends not only on the future outlook of the potential Fusion Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Fusion Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 65.6 M | |
| Cash And Short Term Investments | 234.1 M |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Fusion Stock
If you are still planning to invest in Fusion Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Fusion Pharmaceuticals' history and understand the potential risks before investing.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |